| Year | Client | Period | Income | Expenses | Doc |
|---|---|---|---|---|---|
| 2026 | BEREN THERAPEUTICS |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | — | |
| 2026 | BEAM THERAPEUTICS |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$10,000 | — | |
| 2026 | AGIOS PHARMACEUTICALS |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$10,000 | — | |
| 2026 | BEREN THERAPEUTICS |
2nd Quarter (Apr 1 - June 30) Registration |
— | — | |
| 2026 | BEAM THERAPEUTICS |
2nd Quarter (Apr 1 - June 30) Registration |
— | — | |
| 2026 | AGIOS PHARMACEUTICALS |
2nd Quarter (Apr 1 - June 30) Registration |
— | — |
| Client | Filings | Total Income |
|---|---|---|
| BEAM THERAPEUTICS | 2 | $10,000 |
| AGIOS PHARMACEUTICALS | 2 | $10,000 |
| BEREN THERAPEUTICS | 2 | — |
| Name | Disclosed Prior Position |
|---|---|
| GREG CHESMORE |